Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Madison, Wisconsin 25 trials found
New Search
Filter
Trial Phase
Study Type
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
PHASE3INTERVENTIONAL Miami, Florida +4 more
RECRUITING
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
PHASE2, PHASE3INTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
N/AOBSERVATIONAL Mesa, Arizona +4 more
RECRUITING
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
PHASE2, PHASE3INTERVENTIONAL Long Beach, California +4 more
RECRUITING
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NAINTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
PHASE2INTERVENTIONAL Chicago, Illinois +3 more
RECRUITING
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
PHASE1INTERVENTIONAL Orange, California +4 more
RECRUITING
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
PHASE2INTERVENTIONAL Chicago, Illinois +4 more
RECRUITING
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
PHASE3INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
PHASE2INTERVENTIONAL Aurora, Colorado +4 more
RECRUITING
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
PHASE2INTERVENTIONAL Chicago, Illinois +1 more
RECRUITING
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
PHASE1INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
PHASE2INTERVENTIONAL Iowa City, Iowa +1 more
RECRUITING
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
N/AOBSERVATIONAL Anchorage, Alaska +4 more
RECRUITING
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
PHASE1INTERVENTIONAL Colorado Springs, Colorado +4 more
RECRUITING
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type